Sea Pharmaceuticals specializes in the development of new oral molecules for the treatment of tinnitus and epilepsy.
Sea Pharmaceuticals has raised $417K in total funding. The most recent round was Undisclosed. The last funding was announced in February 2025.
Sea Pharmaceuticals is headquartered in Cambridge, United States.
Sea Pharmaceuticals specializes in the development of new oral molecules for the treatment of tinnitus and epilepsy.
Sea Pharmaceuticals is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sea Pharmaceuticals — Funding & Investors." VCBacked, February 10, 2025, https://www.vcbacked.co/company/sea-pharmaceuticals. Accessed August 14, 2026.
VCBacked. (2025). Sea Pharmaceuticals — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/sea-pharmaceuticals
{{cite web |title=Sea Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/sea-pharmaceuticals |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated